These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15539739)

  • 1. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review.
    Steurer-Stey C; Bachmann LM; Steurer J; Tramèr MR
    Chest; 2004 Nov; 126(5):1645-55. PubMed ID: 15539739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.
    Arandjus C; Black PN; Poole PJ; Wood Baker R; Steurer-Stey C
    Respir Med; 2006 Oct; 100(10):1671-81. PubMed ID: 16934969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
    Solèr M; Mütterlein R; Cozma G;
    Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review.
    Sprenkle MD; Niewoehner DE; MacDonald R; Rutks I; Wilt TJ
    COPD; 2005 Mar; 2(1):167-75. PubMed ID: 17136978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review.
    Stey C; Steurer J; Bachmann S; Medici TC; Tramèr MR
    Eur Respir J; 2000 Aug; 16(2):253-62. PubMed ID: 10968500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease.
    Li J; Zheng JP; Yuan JP; Zeng GQ; Zhong NS; Lin CY
    Chin Med J (Engl); 2004 Jun; 117(6):828-34. PubMed ID: 15198881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
    Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis.
    Lee JS; Park DA; Hong Y; Jo KW; Lee SW; Huh JW; Oh YM; Lee SD
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):153-62. PubMed ID: 23317949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis.
    Cazzola M; Anapurapu S; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of OM-85 BV in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Pan L; Jiang XG; Guo J; Tian Y; Liu CT
    J Clin Pharmacol; 2015 Oct; 55(10):1086-92. PubMed ID: 25903441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.
    Poole PJ; Black PN
    BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease].
    Llor C; Naberan K; Cots JM; Molina J; Ros F; Miravitlles M;
    Arch Bronconeumol; 2006 Apr; 42(4):175-82. PubMed ID: 16735014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance.
    Troiano G; Messina G; Nante N
    J Prev Med Hyg; 2021 Jun; 62(2):E564-E573. PubMed ID: 34604601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review.
    Steurer-Stey C; Lagler L; Straub DA; Steurer J; Bachmann LM
    Eur J Pediatr; 2007 Apr; 166(4):365-76. PubMed ID: 17115184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between use of SGLT2is and incidence of respiratory and infectious diseases and site-specific fractures: a meta-analysis based on 32 large RCTs.
    Wang Y; Zhou X
    Eur J Clin Pharmacol; 2024 Apr; 80(4):563-573. PubMed ID: 38267688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysis.
    Liu KX; Xu B; Wang J; Zhang J; Ding HB; Ariani F; Qu JM; Lin QC
    J Thorac Dis; 2014 Mar; 6(3):221-9. PubMed ID: 24624286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis.
    Orcel B; Delclaux B; Baud M; Derenne JP
    Eur Respir J; 1994 Mar; 7(3):446-52. PubMed ID: 8013600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.